A 2024 FDA analysis noted depression reports in post-market surveillance data, yet placebo-controlled trials have not consistently demonstrated a causal link
We believe understanding how BPC 157 for healing works can help you make informed decisions about your wellness journey
Early water weight loss is common
If you have unstable angina, recent heart attack, or uncontrolled arrhythmia, your provider will discuss whether semaglutide is appropriate for your specific situation
Adriane Fugh-Berman explains how visuals in ads and cherry-picked safety disclosures are among the deceptive tactics that have been used for years to promote drugs directly to consumers
I believe realizing the full potential of GLP1 therapies will require ongoing research, innovative policy approaches, and collaboration among stakeholders to balance immediate financial pressures and future health gains in a sustainable way